Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

  1. Home
  3. Research Domains
  5. Biomedical And Clinical Sciences
  7. Oncology And Carcinogenesis
  9. Predictive And Prognostic Markers
  11. Anatomical And Biological Considerations To Determine Resectability In Pancreatic Cancer

Anatomical and Biological Considerations to Determine Resectability in Pancreatic Cancer

Ingmar F Rompen1,2, Joseph R Habib1, Christopher L Wolfgang1

  • 1Department of Surgery, The NYU Grossman School of Medicine and NYU Langone Health, New York, NY 10016, USA.

Cancers
|February 10, 2024

Related Experiment Videos

An Orthotopic Resectional Mouse Model of Pancreatic Cancer
07:17

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

Published on: September 24, 2020

10.6K
DIPLOMA Approach for Standardized Pathology Assessment of Distal Pancreatectomy Specimens
10:38

DIPLOMA Approach for Standardized Pathology Assessment of Distal Pancreatectomy Specimens

Published on: February 1, 2020

7.4K
Laparoscopic Radical Antegrade Modular Pancreatosplenectomy via Dorsal-Caudal Artery Approach for Pancreatic Neck-Body Cancer
12:07

Laparoscopic Radical Antegrade Modular Pancreatosplenectomy via Dorsal-Caudal Artery Approach for Pancreatic Neck-Body Cancer

Published on: November 18, 2022

3.8K

View abstract on PubMed

Summary
This summary is machine-generated.

Pancreatic cancer survival remains low due to late diagnosis and spread. Integrating biological factors with anatomical staging could improve surgical decisions and patient outcomes for pancreatic ductal adenocarcinoma.

Area of Science:

  • Oncology
  • Surgical Oncology
  • Gastroenterology

Background:

  • Pancreatic ductal adenocarcinoma (PDAC) has a dismal 5-year survival rate of 12%.
  • Late diagnosis and early systemic spread contribute to poor patient outcomes.
  • Despite aggressive surgical interventions, approximately 40% of patients experience early disease recurrence.

Purpose of the Study:

  • To review current literature on defining anatomical and biological resectability in pancreatic cancer.
  • To explore integrating biological criteria into staging systems to improve surgical decision-making.
  • To identify patients most likely to benefit from aggressive surgical resection.

Main Methods:

  • Literature review of anatomical and biological factors influencing pancreatic cancer resectability.
Keywords:
CA19-9biological stagingbiomarkerspancreatic ductal adenocarcinoma

Related Experiment Videos

An Orthotopic Resectional Mouse Model of Pancreatic Cancer
07:17

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

Published on: September 24, 2020

10.6K
DIPLOMA Approach for Standardized Pathology Assessment of Distal Pancreatectomy Specimens
10:38

DIPLOMA Approach for Standardized Pathology Assessment of Distal Pancreatectomy Specimens

Published on: February 1, 2020

7.4K
Laparoscopic Radical Antegrade Modular Pancreatosplenectomy via Dorsal-Caudal Artery Approach for Pancreatic Neck-Body Cancer
12:07

Laparoscopic Radical Antegrade Modular Pancreatosplenectomy via Dorsal-Caudal Artery Approach for Pancreatic Neck-Body Cancer

Published on: November 18, 2022

3.8K
  • Analysis of current anatomical staging systems for pancreatic cancer.
  • Discussion of the impact of systemic disease burden on surgical outcomes.

    • Main Results:

    • Anatomical staging systems alone do not account for systemic disease burden.
    • Patients with anatomically resectable disease but undetected systemic disease may not benefit from resection.
    • Integrating biological criteria could help select patients for complex resections who are likely to benefit.

    Conclusions:

    • Current anatomical staging for pancreatic cancer may lead to futile resections.
    • Incorporating biological assessment alongside anatomical staging is crucial for optimizing treatment strategies.
    • A combined approach can help avoid unnecessary morbidity and improve survival for select pancreatic cancer patients.
    pancreatic neoplasms
    resectability
    tumor biology